Haring and colleagues (23) explored the impact of antipsychotic drug treatment on serum EGF in 38 schizophrenia patients before and after 7 months of medical intervention and found significantly elevated serum EGF in first-episode schizophrenia patients compared to controls and below normal levels following treatment. This evidence concerns the gene EGF and schizophrenia.